期刊文献+

人类疱疹病毒8型传播途径的研究进展 被引量:3

原文传递
导出
摘要 人类疱疹病毒8型(HHV-8)的传播途径包括唾液传播、精液传播、器官移植传播和血液传播,其中是否通过输血传播始终有争议。在低流行率的北美地区,多个研究小组的研究结果显示,在HHV-8血清学阳性的献血者中未发现HHV-8DNA;而来自高流行率地区的乌干达的研究却表明HHV-8可通过输血传播给受血者,甚至引起死亡。本文在介绍HHV-8的基本特点、流行特征和传播途径的基础上,对HHV-8通过输血传播的可能性进行分析。在目前情况下,延长血液冷藏时间、白细胞去除和病毒灭活等技术,在一定程度上降低了HHV-8输血传播的风险,保证输血安全。
机构地区 江苏省血液中心
出处 《中国预防医学杂志》 CAS 2014年第5期537-540,共4页 Chinese Preventive Medicine
基金 江苏省卫生厅国际交流支撑计划(JSH-2013-019)
  • 相关文献

参考文献35

  • 1Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS associated Kaposi's sarcoma [J].Science, 1994, 266 (5192): 1865-1869.
  • 2Gantt S, Casper C. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antivlral treatment [J].Curr Opin Infect Dis, 2012; 24 (4):295 -301.
  • 3Wen KW, Damania B. Kaposi sarcoma associated herpesvir us (KSHV) : Molecular biology and oncogenesis [J]. Canc- er Lett, 2010, 289 (2): 140 -150.
  • 4Beyari MM, Hodgson TA, Cook RD. Multiple human her pesvirus 8infection [J].J Infect Dis, 2003, 188 (5): 678- 689.
  • 5Dollard SC, Butler LM, Jones AM, et al. Substantial re gional differences in human herpesvirus 8 seroprevalence in sub Saharan Africa: insights on the origin of the " Kaposi's sarcoma Belt" [J]. lnt J Cancer, 2010, 127 (10): 2395 -401.
  • 6Cattani P, Cerimele F, Porta D, etal. Age specific sero- prevalence of human herpesvirus 8 in Mediterranean regions [J].ClinMicrobiolInfect, 2003, 9 (4): 274-279.
  • 7Borges JD, Souza VA, Giambartolomei C, et al. Trans mission of human herpesvirus type 8 infection within fami- lies in American indigenous populations from the Brazilian Amazon [J].J Infect Dis, 2012, 205 (12): 1869-1876.
  • 8Zhang T, Shao X, Chen Y, etal. Human herpesvirus 8 seroprevalence, China [J].Emerg Infect Dis, 2012, 18 (1): 150-152.
  • 9Chen N, Nelson KE, Jenkins FJ. etal. Seroprevalence of human herpesvirus 8 infection in Northern Thailand [J].Clin Infect Dis, 2004, 39 (7): 1052-1058.
  • 10Dukers NH, Rezza G. Human herpesvirus 8 epidemiology= what we do and do not know [J].AIDS. 2003, 17 (12): 1717-1730.

二级参考文献15

  • 1齐眉,赵蔚明,周亚滨,栾怡,卞继锋,王红,程轶喆,刘娟,唐伟,于晗.济南地区献血者中人疱疹病毒8型(HHV-8)IgG抗体的检测及相关危险因素分析[J].山东大学学报(医学版),2006,44(4):328-331. 被引量:10
  • 2Sarid R, Olsen SJ, Moore PS, et al. Kaposi's sarcoma asso- ciated herpesvirus: epidemiology, virology, and molecular biol- ogy [J ]. Adv Virus Re.s, 1999,52 : 139 - 232.
  • 3Moore PS, Gao SJ, Dominguez G, et al. Primary character- ization of a herpesvirus agent associated with Kaposi's sarco- mac [J]. J Virol,1996,70(1):549-558.
  • 4Chang Y, Cesannan E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [J].Science, 1994,266: 1865-1869.
  • 5Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part2:pathogenesis,Castleman's disease,and pleural effusion lymphoma[j]. Lancet Infect Dis, 2002,2:344-352.
  • 6Lennette ET, Bhckhoura DJ, Levy JA. Antibodies to human herpesvirus 8 in the general population and in Kaposi's sarcoma patients [J]. Lancet, 1996,348:858-861.
  • 7Sheldon J, Henry S, Mourad M, et al. Human herpes virus 8 infection in kidney transplant patients in Belgium [J]. Nephrol Dial Transplant, 2000, 15: 1443-1445.
  • 8Simpson GB, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant eapsid protein and latent immunofluorescence antigen [J]. Lancet, 1996,348 (9035):1133-1138.
  • 9Pellett PE,Wright DJ.Ablashi DV.et al.Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors[J].Transfusion 2003.42:1260-1268.
  • 10Huang LM, Huang SY, Chen M, et al. Geographical difference in human herpesvirus 8 seroepidcmiology:a survey of 1201 individuals in Asia [J]. J Med Virol, 2000,60:290-293.

共引文献5

同被引文献59

  • 1刘富金,孙晗笑.人类疱疹病毒7型感染CD4^+T淋巴细胞的意义[J].中国免疫学杂志,2004,20(7):510-512. 被引量:2
  • 2田伟,李俊燕,于志湖,张树孝.扁平苔藓发病机制的研究进展[J].中国麻风皮肤病杂志,2005,21(8):632-634. 被引量:8
  • 3肖云贵,许金波.血液病毒灭活机理及其效果评价[J].中国输血杂志,2005,18(5):425-427. 被引量:10
  • 4WEN KW,DAMANIA B. Kaposi sarcoma associated herpesvir us(KSHV):molecular biology and oncogenesis[J]. Cancer Lett,2010,289(2):140.
  • 5DEVINE DV, SERRANO K. Preparation of blood products for transfusion:is there a best method? [J]. Biologicals,2012,40(3) : 187.
  • 6FAST LD,NEVOLA M,TAVARES J,et al. Treatment of whole blood with riboflavin plus ultraviolet light,an alternative to gam ma irradiation in the prevention of transfusion associated graftversus-host disease? [J]. Transfusion,2013,53(2) :373.
  • 7COMPSTON LI, SARKOBIE F, LI C, et al. Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions[J].. J Virol Methods, 2008,151 ( 1 ) : 47.
  • 8SALUNK HE V, VAN DER MEER PF, DE KORTE D, et al. Development of blood transfusion product pathogen reduction treatments:a review of methods, current applications and demands[J].. Transfus Apber Sci,2015,52(1):19.
  • 9DOI.LARD SC,BUTLER LM,JONES AM,et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa= insights on the origin of the " Kaposi's sarcomabelt"[J]. Int J Cancer,2010,127(10) : 2395.
  • 10BORGES JD,SOUZA VA,(;IAMBARTOLOMEI C,et al. Transmission of human herpesvirus type 8 infection within families in American indigenous populations from the Brazilian Amazon[J]. J Infect Dis,2012,205(12) : 1869.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部